Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1996-12-12
pubmed:abstractText
Control of the acute phase of Trypanosoma cruzi infections is critically dependent on cytokine-mediated macrophage activation to intracellular killing. We investigated the roles of IL-10, TNF, IFN-gamma, and IL-12 in the control of parasitism by innate and specific immunity. Mice with disrupted IL-10 genes (IL-10 KO) infected with Y strain T. cruzi have lower parasite numbers in the blood and tissues and higher IFN-gamma and nitric oxide (NO) production by spleen cells than wild type (WT) mice. Treatment of IL-10 KO and WT mice with recombinant IL-10 resulted in increased parasitemia. Mice with disrupted recombinase-activating genes (RAG/KO) that lack B and T cells provided a model for determining the importance of innate immunity to resistance. RAG/KO and WT mice had similar parasitemia levels until Day 13 of infection, suggestive of effective control of parasitism by the innate immune system during the early phase of infection; from them on parasitemia was higher in RAG/KO. Double RAG/IL-10 KO mice and RAG/KO mice had superimposable parasitemia curves, indicating that in the absence of T and B cells, endogenous IL-10 does not limit the efficacy of the innate immune system. Treatment of infected RAG/KO, IL-10/KO, and WT mice with anti-IFN-gamma, anti-TNF, or anti-IL-12 neutralizing mAbs increased parasitemia levels showing the importance of endogenous production of these cytokines in the control of parasitism by innate and specific immune responses. Spleen cells from anti-IL 12-treated WT mice had diminished production of IFN-gamma and NO, suggesting that early IFN-gamma synthesis is most dependent on IL-12 stimulation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0014-4894
pubmed:author
pubmed:issnType
Print
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
231-44
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:8932773-Animals, pubmed-meshheading:8932773-Antibodies, Monoclonal, pubmed-meshheading:8932773-Cells, Cultured, pubmed-meshheading:8932773-Chagas Disease, pubmed-meshheading:8932773-Dendritic Cells, pubmed-meshheading:8932773-Female, pubmed-meshheading:8932773-Immunity, Active, pubmed-meshheading:8932773-Immunity, Innate, pubmed-meshheading:8932773-Interferon-gamma, pubmed-meshheading:8932773-Interleukin-10, pubmed-meshheading:8932773-Interleukin-12, pubmed-meshheading:8932773-Keratinocytes, pubmed-meshheading:8932773-Lymphocytes, pubmed-meshheading:8932773-Macrophages, pubmed-meshheading:8932773-Male, pubmed-meshheading:8932773-Mice, pubmed-meshheading:8932773-Nitrites, pubmed-meshheading:8932773-Parasitemia, pubmed-meshheading:8932773-Spleen, pubmed-meshheading:8932773-Trypanosoma cruzi, pubmed-meshheading:8932773-Tumor Necrosis Factor-alpha
pubmed:year
1996
pubmed:articleTitle
Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
pubmed:affiliation
Departamento de Imunologia, Universidade de Säo Paulo, Brasil.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't